# The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension

> **NCT05948644** · PHASE1 · COMPLETED · sponsor: **Vigonvita Life Sciences** · enrollment: 10 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** TPN171H

## Key facts

- **NCT ID:** NCT05948644
- **Lead sponsor:** Vigonvita Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-08
- **Primary completion:** 2020-10-14
- **Final completion:** 2020-10-14
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-10-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05948644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05948644, "The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05948644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*